These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23920769)

  • 1. A proposed dynamic dosing scheme to secure the target plasma drug concentrations based on the precision of the AUC estimate.
    Tsuruta H; Wada T
    Stud Health Technol Inform; 2013; 192():995. PubMed ID: 23920769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children.
    Trame MN; Bergstrand M; Karlsson MO; Boos J; Hempel G
    Clin Cancer Res; 2011 Nov; 17(21):6867-77. PubMed ID: 21918171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Dupuis LL; Sibbald C; Schechter T; Ansari M; Gassas A; Théorêt Y; Kassir N; Champagne MA; Doyle J
    Biol Blood Marrow Transplant; 2008 May; 14(5):576-82. PubMed ID: 18410900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited sampling strategies to estimate the area under the concentration-time curve. Biases and a proposed more accurate method.
    Tsuruta H; Fukumoto M; Bax L; Kohno A; Morishita Y
    Methods Inf Med; 2012; 51(5):383-94. PubMed ID: 22614791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.
    de Castro FA; Piana C; Simões BP; Lanchote VL; Della Pasqua O
    Br J Clin Pharmacol; 2015 Oct; 80(4):618-29. PubMed ID: 25819742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan.
    Vaughan WP; Carey D; Perry S; Westfall AO; Salzman DE
    Biol Blood Marrow Transplant; 2002; 8(11):619-24. PubMed ID: 12463481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?
    Buffery PJ; Allen KM; Chin PK; Moore GA; Barclay ML; Begg EJ
    Ther Drug Monit; 2014 Feb; 36(1):86-92. PubMed ID: 24299921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
    Vassal G; Michel G; Espérou H; Gentet JC; Valteau-Couanet D; Doz F; Mechinaud F; Galambrun C; Neven B; Zouabi H; Nguyen L; Puozzo C
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):113-23. PubMed ID: 17393167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
    Salinger DH; Vicini P; Blough DK; O'Donnell PV; Pawlikowski MA; McCune JS
    J Clin Pharmacol; 2010 Nov; 50(11):1292-300. PubMed ID: 20075185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study.
    Nguyen L; Leger F; Lennon S; Puozzo C
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):191-8. PubMed ID: 16133536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin dosing in children: calculation by different formulae.
    Würthwein G; Krefeld B; Gerss J; Boos J
    Onkologie; 2011; 34(1-2):16-22. PubMed ID: 21346380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
    Dupuis LL; Seto W; Teuffel O; Gibson P; Schultz KR; Doyle JD; Gassas A; Egeler RM; Sung L; Schechter T
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of modelling and simulation into the development of intravenous busulfan in paediatrics: an industrial experience.
    Nguyen L
    Fundam Clin Pharmacol; 2008 Dec; 22(6):599-604. PubMed ID: 19049661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing.
    Hughes JH; Long-Boyle J; Keizer RJ
    J Pharmacokinet Pharmacodyn; 2024 Jun; 51(3):279-288. PubMed ID: 38520573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.
    Booth BP; Rahman A; Dagher R; Griebel D; Lennon S; Fuller D; Sahajwalla C; Mehta M; Gobburu JV
    J Clin Pharmacol; 2007 Jan; 47(1):101-11. PubMed ID: 17192508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
    Zwaveling J; den Hartigh J; Lankester AC; Guchelaar HJ; Egeler RM; Bredius RG
    Anticancer Drugs; 2006 Oct; 17(9):1099-105. PubMed ID: 17001185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.
    Ansari M; Théoret Y; Rezgui MA; Peters C; Mezziani S; Desjean C; Vachon MF; Champagne MA; Duval M; Krajinovic M; Bittencourt H;
    Ther Drug Monit; 2014 Feb; 36(1):93-9. PubMed ID: 24061446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.